Background Pharmacotherapy combinations have been shown to improve survival and reduce hospitalisations in adults with ...
Many patients with actionable driver oncogenes (ADOs) are never identified and thus never receive targeted treatment. This study evaluated the economic impact and the potential life-years gained (LYG) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results